Reported Rates of Intraocular Inflammation with Intravitreal Aflibercept Administered via Pre-Filled Syringe or from Vials in Clinical Practice Between 2012 and 2022

PURPOSE: To determine the reported rates of intraocular inflammation (IOI) in patients treated with intravitreal aflibercept (IVT-AFL) 2 mg in routine clinical practice (ie, outside interventional studies), across all indications and within all countries (excluding the United States), with access to...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt-Ott, Ursula, Fitzpatrick, Scott, Hasanbasic, Zoran, Leal, Sergio, Morgan-Warren, Peter, Zhang, Xin, Johnson, Kristian T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886133/
https://www.ncbi.nlm.nih.gov/pubmed/36726365
http://dx.doi.org/10.2147/OPTH.S393519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886133/
https://www.ncbi.nlm.nih.gov/pubmed/36726365
http://dx.doi.org/10.2147/OPTH.S393519

Ejemplares similares